S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

PTC Therapeutics News Headlines (NASDAQ:PTCT)

$54.34
+1.52 (+2.88 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$53.01
Now: $54.34
$55.44
50-Day Range
$48.41
MA: $53.80
$59.36
52-Week Range
$31.49
Now: $54.34
$59.89
Volume707,149 shs
Average Volume894,223 shs
Market Capitalization$3.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.97

Headlines

PTC Therapeutics (NASDAQ PTCT) News Headlines

Source:
DateHeadline
PTC Therapeutics (PTCT) to Release Earnings on MondayPTC Therapeutics (PTCT) to Release Earnings on Monday
www.americanbankingnews.com - February 24 at 5:36 AM
PTC Therapeutics (NASDAQ:PTCT) Rating Lowered to Neutral at CitigroupPTC Therapeutics (NASDAQ:PTCT) Rating Lowered to Neutral at Citigroup
www.americanbankingnews.com - February 20 at 7:45 AM
PTC Therapeutics (NASDAQ:PTCT) Downgraded to Sector Perform at Royal Bank of CanadaPTC Therapeutics (NASDAQ:PTCT) Downgraded to Sector Perform at Royal Bank of Canada
www.americanbankingnews.com - February 20 at 7:45 AM
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Buy" by AnalystsPTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - February 19 at 6:52 PM
PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular DystrophyPTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophy
finance.yahoo.com - February 18 at 12:35 PM
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial ResultsPTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
www.prnewswire.com - February 17 at 5:58 PM
 Analysts Expect PTC Therapeutics, Inc. (NASDAQ:PTCT) Will Post Quarterly Sales of $88.76 Million Analysts Expect PTC Therapeutics, Inc. (NASDAQ:PTCT) Will Post Quarterly Sales of $88.76 Million
www.americanbankingnews.com - February 17 at 5:34 AM
 Brokerages Anticipate PTC Therapeutics, Inc. (NASDAQ:PTCT) to Announce -$0.53 EPS Brokerages Anticipate PTC Therapeutics, Inc. (NASDAQ:PTCT) to Announce -$0.53 EPS
www.americanbankingnews.com - February 15 at 6:25 AM
Equities Analysts Set Expectations for PTC Therapeutics, Inc.s FY2021 Earnings (NASDAQ:PTCT)Equities Analysts Set Expectations for PTC Therapeutics, Inc.'s FY2021 Earnings (NASDAQ:PTCT)
www.americanbankingnews.com - February 10 at 4:23 AM
PTC Therapeutics (NASDAQ:PTCT) Earns Buy Rating from SunTrust BanksPTC Therapeutics (NASDAQ:PTCT) Earns Buy Rating from SunTrust Banks
www.americanbankingnews.com - February 7 at 6:39 AM
Cowen Reaffirms "Hold" Rating for PTC Therapeutics (NASDAQ:PTCT)Cowen Reaffirms "Hold" Rating for PTC Therapeutics (NASDAQ:PTCT)
www.americanbankingnews.com - February 6 at 1:44 PM
PTC Therapeutics down 6% premarket on risdiplam dataPTC Therapeutics down 6% premarket on risdiplam data
seekingalpha.com - February 6 at 12:20 PM
Why PTC Therapeutics Stock Is Plummeting TodayWhy PTC Therapeutics Stock Is Plummeting Today
www.fool.com - February 6 at 12:20 PM
Is PTC Therapeutics, Inc. (NASDAQ:PTCT) A Volatile Stock?Is PTC Therapeutics, Inc. (NASDAQ:PTCT) A Volatile Stock?
finance.yahoo.com - February 6 at 12:20 PM
SUNFISH Pivotal Results for Risdiplam (RG7916)...SUNFISH Pivotal Results for Risdiplam (RG7916)...
www.benzinga.com - February 6 at 7:19 AM
SUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular AtrophySUNFISH Pivotal Results for Risdiplam (RG7916) Demonstrate Medically Meaningful Benefit in Broadest Age Group of Patients Studied with Type 2 and 3 Spinal Muscular Atrophy
www.prnewswire.com - February 6 at 6:37 AM
Traders Purchase Large Volume of PTC Therapeutics Call Options (NASDAQ:PTCT)Traders Purchase Large Volume of PTC Therapeutics Call Options (NASDAQ:PTCT)
www.americanbankingnews.com - February 4 at 8:51 AM
PTC Therapeutics (NASDAQ:PTCT) and Perrigo (NASDAQ:PRGO) Financial AnalysisPTC Therapeutics (NASDAQ:PTCT) and Perrigo (NASDAQ:PRGO) Financial Analysis
www.americanbankingnews.com - February 3 at 10:27 PM
Noteworthy Monday Option Activity: PTCT, LITE, MATWNoteworthy Monday Option Activity: PTCT, LITE, MATW
www.nasdaq.com - February 3 at 7:39 PM
PTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular DystrophyPTC Therapeutics Announces First Publication of Real-World Data Showing Translarnaä (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy
finance.yahoo.com - February 3 at 8:08 AM
PTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe ConferencePTC Therapeutics to Host A Conference Call to Review Part 2 of the SUNFISH Clinical Trial Data at the SMA Europe Conference
finance.yahoo.com - February 3 at 8:08 AM
Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular AtrophyRisdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy
www.prnewswire.com - January 23 at 1:30 AM
BRIEF-PTC Therapeutics Inc Sees Total Unaudited Revenue For 2019 Was About $306 MillionBRIEF-PTC Therapeutics Inc Sees Total Unaudited Revenue For 2019 Was About $306 Million
www.msn.com - January 13 at 11:29 AM
PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare ConferencePTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference
finance.yahoo.com - January 13 at 11:29 AM
Notable Tuesday Option Activity: FB, PTCT, AAPLNotable Tuesday Option Activity: FB, PTCT, AAPL
www.nasdaq.com - January 7 at 4:25 PM
Why PTC Therapeutics, Inc.'s (NASDAQ:PTCT) CEO Pay Matters To YouWhy PTC Therapeutics, Inc.'s (NASDAQ:PTCT) CEO Pay Matters To You
finance.yahoo.com - January 7 at 4:25 PM
PTC Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare ConferencePTC Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 4:25 PM
Hedge Fund Favorites vs. PTC Therapeutics, Inc. (PTCT) In 2019Hedge Fund Favorites vs. PTC Therapeutics, Inc. (PTCT) In 2019
finance.yahoo.com - December 26 at 12:40 PM
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 13 at 11:20 PM
The Therapeutics (NASDAQ:PTCT) Share Price Is Up 289% And Shareholders Are Boasting About ItThe Therapeutics (NASDAQ:PTCT) Share Price Is Up 289% And Shareholders Are Boasting About It
finance.yahoo.com - December 3 at 12:17 PM
PTC Therapeutics to Present at the Evercore ISI 2nd Annual HealthCONx ConferencePTC Therapeutics to Present at the Evercore ISI 2nd Annual HealthCONx Conference
finance.yahoo.com - November 19 at 9:07 AM
PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient IdentificationPTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identification
finance.yahoo.com - November 18 at 1:04 PM
Risdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular AtrophyRisdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular Atrophy
finance.yahoo.com - November 11 at 1:06 AM
Edited Transcript of PTCT earnings conference call or presentation 29-Oct-19 8:30pm GMTEdited Transcript of PTCT earnings conference call or presentation 29-Oct-19 8:30pm GMT
finance.yahoo.com - October 30 at 7:32 AM
BRIEF-PTC Therapeutics Posts Qtrly Loss Per Share Of $1.06BRIEF-PTC Therapeutics Posts Qtrly Loss Per Share Of $1.06
www.msn.com - October 30 at 12:32 AM
PTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue EstimatesPTC Therapeutics (PTCT) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - October 30 at 12:32 AM
PTC Therapeutics EPS misses by $0.27, misses on revenuePTC Therapeutics EPS misses by $0.27, misses on revenue
seekingalpha.com - October 29 at 7:32 PM
PTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate UpdatePTC Therapeutics Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
finance.yahoo.com - October 29 at 7:32 PM
PTC Therapeutics Q3 2019 Earnings PreviewPTC Therapeutics Q3 2019 Earnings Preview
seekingalpha.com - October 28 at 5:35 PM
When Will PTC Therapeutics, Inc. (NASDAQ:PTCT) Become Profitable?When Will PTC Therapeutics, Inc. (NASDAQ:PTCT) Become Profitable?
finance.yahoo.com - October 24 at 2:02 PM
Is PTC Therapeutics, Inc. (PTCT) A Good Stock To Buy ?Is PTC Therapeutics, Inc. (PTCT) A Good Stock To Buy ?
finance.yahoo.com - October 23 at 10:39 PM
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2019 Financial ResultsPTC Therapeutics to Host Conference Call to Discuss Third Quarter 2019 Financial Results
finance.yahoo.com - October 15 at 12:39 PM
PTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid ManufacturingPTC Therapeutics Establishes Strategic Collaboration with Aldevron to Support GMP Plasmid Manufacturing
finance.yahoo.com - October 7 at 11:19 AM
PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular DystrophyPTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy
finance.yahoo.com - October 4 at 5:30 PM
Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society CongressRisdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress
finance.yahoo.com - October 2 at 4:41 PM
Heres Why PTC Therapeutics Fell as Much as 12.5% TodayHere's Why PTC Therapeutics Fell as Much as 12.5% Today
www.fool.com - September 18 at 5:01 PM
PTC down 8% premarket after pricing offeringsPTC down 8% premarket after pricing offerings
seekingalpha.com - September 18 at 11:59 AM
PTC Therapeutics Announces Pricing of Private Offering of Convertible Senior NotesPTC Therapeutics Announces Pricing of Private Offering of Convertible Senior Notes
finance.yahoo.com - September 18 at 11:59 AM
Is Therapeutics (NASDAQ:PTCT) Using Debt Sensibly?Is Therapeutics (NASDAQ:PTCT) Using Debt Sensibly?
finance.yahoo.com - September 18 at 11:59 AM
PTC Therapeutics launches convertible debt offering; shares down 5% after hoursPTC Therapeutics launches convertible debt offering; shares down 5% after hours
seekingalpha.com - September 17 at 6:00 PM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel